HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1391
https://www.valueinhealthjournal.com/article/S1098-3015(24)01506-7/fulltext
Title :
HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01506-7&doi=10.1016/j.jval.2024.03.1391
First page :
Section Title :
Open access? :
No
Section Order :
10783